One-Year Clinical Outcomes among Patients with Metabolic Syndrome and Acute Myocardial Infarction-Reference-Cited by-同舟云学术

One-Year Clinical Outcomes among Patients with Metabolic Syndrome and Acute Myocardial Infarction

Published:2013 Issue:8 Volume:43 Page:519
ISSN:1738-5520
Container-title:Korean Circulation Journal
language:en
Short-container-title:Korean Circ J

Author:

Ji Mi Seon¹,Jeong Myung Ho¹²,Ahn Youngkeun¹²,Kim Young Jo³,Chae Shung Chull⁴,Hong Taek Jong⁵,Seong In Whan⁶,Chae Jei Keon⁷,Kim Chong Jin⁸,Cho Myeong Chan⁹,Rha Seung-Woon¹⁰,Bae Jang Ho¹¹,Seung Ki Bae¹²,Park Seung Jung¹³,

Affiliation:

1. Chonnam National University Hospital, Gwangju, Korea.

2. Korea Cardiovascular Stent Research Institute of Chonnam National University, Gwangju, Korea.

3. Yeungnam University Hospital, Daegu, Korea.

4. Kyungpook National University Hospital, Daegu, Korea.

5. Pusan National University Hospital, Busan, Korea.

6. Chungnam National University Hospital, Daejeon, Korea.

7. Chunbuk National University Hospital, Jeonju, Korea.

8. Kyung Hee University Hospital, Seoul, Korea.

9. Chungbuk National University Hospital, Cheongju, Korea.

10. Korea University Guro Hospital, Seoul, Korea.

11. Konyang University, Daejeon, Korea.

12. The Catholic University of Korea, Seoul St. Mary's Hospital, Seoul, Korea.

13. Asan Medical Center, Seoul, Korea.

Funder

Korean Circulation Society

Publisher

The Korean Society of Cardiology

Subject

Cardiology and Cardiovascular Medicine,Internal Medicine

Link

https://synapse.koreamed.org/pdf/10.4070/kcj.2013.43.8.519

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of metabolic syndrome on clinical characteristics and one-year outcomes of patients undergoing primary percutaneous coronary intervention;2023-09-05

2. Impact of Metabolic Syndrome and Its Components on Clinical Severity and Long-Term Prognosis in Patients With Premature Myocardial Infarction;Frontiers in Endocrinology;2022-06-30

3. Impact of metabolic syndrome on clinical severity and long-term prognosis in patients with myocardial infarction with ST-segment elevation;Hellenic Journal of Cardiology;2018-07

4. Impaired Fasting Glucose Is the Major Determinant of the 20-Year Mortality Risk Associated With Metabolic Syndrome in Nondiabetic Patients With Stable Coronary Artery Disease;J AM HEART ASSOC;2017

5. Efficacy of Ace Inhibition with Zofenopril, Lisinopril, or Ramipril in Postacute Myocardial Infarction Patients With or Without Metabolic Syndrome: A Pooled Individual Data Analysis of Four Randomized, Double-Blind, Controlled, Prospective Studies;Metabolic Syndrome and Related Disorders;2017-08